Virtu Financial Completes Term Loan Repricing and Prepayment
Jan 08, 2018 13:03 pm UTC| Business
NEW YORK, Jan. 08, 2018 -- Virtu Financial, Inc. (NASDAQ:VIRT) (the “Company”), a leading technology-enabled market maker and liquidity provider to the global financial markets, today announced the completion of a...
Cisco Showcases Multicloud Video Innovation at CES 2018
Jan 08, 2018 13:03 pm UTC| Business
LAS VEGAS, Jan. 08, 2018 -- CES – At CES this week, Cisco is demonstrating for its global service provider customers innovation and use cases for cloud-powered, app-driven video services, ranging from cloud DVR to OTT...
Document Security Systems, Inc. Names IT Executive Vincent Lum President of DSS Asia
Jan 08, 2018 13:03 pm UTC| Business
ROCHESTER, N.Y., Jan. 08, 2018 -- Document Security Systems, Inc. (NYSE American:DSS), a leader in anti-counterfeit, authentication, and diversion protection technologies whose products and solutions are used by...
CES 2018: Cisco Announces Infinite Broadband Unlocked for cBR-8
Jan 08, 2018 13:03 pm UTC| Business
LAS VEGAS, Jan. 08, 2018 -- CES -- Cisco today announced a new, highly flexible DOCSIS licensing plan for its cable operator customers using the Cisco® Converged Broadband Router (cBR-8) platform to deliver high-speed...
Interpace Diagnostics Recognized as One of the Top 20 Bioinformatics Solutions Providers
Jan 08, 2018 13:03 pm UTC| Business
PARSIPPANY, N.J., Jan. 08, 2018 -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or the “Company”), a fully integrated commercial and bioinformatics company that provides clinically useful molecular...
Alder Announces $250 Million Committed Equity Financing
Jan 08, 2018 13:03 pm UTC| Business
BOTHELL, Wash., Jan. 08, 2018 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it has...
Jan 08, 2018 13:03 pm UTC| Business
BOTHELL, Wash., Jan. 08, 2018 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it has...